Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

13.42 +0.06 (+0.45%)
Streaming Delayed Price Updated: 2:56 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
AVTR Q1 Earnings Call: CEO Transition and Margin Focus Amid Weak Market Conditions
Life sciences company Avantor (NYSE:AVTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was in... 
Via StockStory
Topics Economy World Trade
Exposures Supply Chain Tariff
Q1 Earnings Highs And Lows: Avantor (NYSE:AVTR) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Avantor (NYSE:AVTR) and the best and worst... 
Via StockStory
Topics Economy
Exposures Supply Chain
An Overview of Avantor's Earnings
Via Benzinga
3 Small-Cap Stocks with Mounting Challenges
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Goldman Sachs Downgrades Avantor As Shares Spiral 60% Since 2021: 'We Wrongly Assumed...'
Avantor missed Q1 sales estimates and faced multiple analyst downgrades as concerns mount over growth, competition, and product performance. 
Via Benzinga
Demystifying Avantor: Insights From 16 Analyst Reviews
Via Benzinga
Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Avantor Analysts Cut Their Forecasts After Q1 Results
Via Benzinga
3 Hated Stocks in the Doghouse
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
This Eli Lilly Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday
Via Benzinga
Why Avantor (AVTR) Shares Are Falling Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 21.2% in the afternoon session after the company reported a weak first-quarter 2025 performance, as its organic revenue and total sales both... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift
Avantor matched EPS expectations but missed revenue targets and cut its outlook as its CEO steps down and cost-saving plans ramp up. 
Via Benzinga
Avantor (NYSE:AVTR) Misses Q1 Revenue Estimates
Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was... 
Via StockStory
Topics Economy
Exposures Supply Chain
Earnings Scheduled For April 25, 2025
Via Benzinga
Earnings To Watch: Avantor (AVTR) Reports Q1 Results Tomorrow
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Economy Tariff
Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Agilent (NYSE:A) and its peers. 
Via StockStory
Topics Economy
Exposures Supply Chain
Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks
Let’s dig into the relative performance of Avantor (NYSE:AVTR) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. 
Via StockStory
Topics Economy
Exposures Supply Chain
A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack
Let’s dig into the relative performance of Mettler-Toledo (NYSE:MTD) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. 
Via StockStory
Topics Economy
Exposures Supply Chain
3 Reasons AVTR is Risky and 1 Stock to Buy Instead
Shareholders of Avantor would probably like to forget the past six months even happened. The stock dropped 38.1% and now trades at $15.67. This was partly due to its softer quarterly results and might... 
Via StockStory
3 Value Stocks in the Doghouse
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch
Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. 
Via StockStory
Topics Economy
Exposures Supply Chain
3 Healthcare Stocks Walking a Fine Line
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Waters Corporation (NYSE:WAT) and its peers. 
Via StockStory
Topics Economy
Exposures Supply Chain
Q4 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks
Looking back on research tools & consumables stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Sotera Health Company (NASDAQ:SHC) and its peers. 
Via StockStory
Topics Economy
Exposures Supply Chain
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bruker (NASDAQ:BRKR) and its peers. 
Via StockStory
Topics Economy
Exposures Supply Chain
Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers. 
Via StockStory
Topics Economy
Exposures Supply Chain
Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst... 
Via StockStory
Topics Economy
Exposures Supply Chain
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSE:RVTY) and the best and worst... 
Via StockStory
Topics Economy
Exposures Supply Chain
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.